Elephants and other large
animals have lower chance of having
cancer because they have evolved their own ways to protect themselves
against the disease A new study
reveals how elephants do
it An old gene that was no longer functional was recycled from the vast “genome
junkyard” to increase the sensitivity of elephant cells to DNA damage, enabling
them to cull potentially cancerous cells early. The incidence of cancer does
not appear to correlate with the number of cells in an organism or its
lifespan. In fact, researchers find that larger, longer-lived mammals have
fewer cases of cancer.
The fact that larger animals like elephants do not have high rates
of cancer
suggests that they have evolved
special cancer suppression mechanisms. In
2015, Joshua Schiffman at the University of Utah School of
Medicine and Carlo Maley at Arizona State University headed a team of researchers who
showed that the elephant genome has about 20 extra duplicates of p53, a canonical tumor suppressor gene. They went on
to suggest that these extra copies of p53 could account, at least
in part, for the elephants’ enhanced cancer suppression capabilities.
Lynch found that most
duplicates of the LIF gene are
pseudogenes—old, mutated, useless copies of genes that survive in the genome by
chance. The exception, however, is the LIF6 gene
sequence, which unlike the others has not accumulated random mutations,
implying that natural selection is preserving it.
“We think that LIF6 is a refunctionalized
pseudogene,” Lynch said. That is, the elephant LIF6 re-evolved into a functional gene from a
pseudogene ancestor. Because it came back from the dead and plays a role in
cell death, Lynch called it a “zombie gene.”
No comments:
Write comments